Community-acquired pneumonia.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Revista clínica española (Ed. impresa)

• Publication date

  2015-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.rce.2015.06.002PMID 26186969
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Characteristics associated with clinician diagnosis of aspiration pneumonia: a descriptive study of afflicted patients and their outcomes.

  2015cited by this paper
• The role of noninvasive positive pressure ventilation in community-acquired pneumonia.

  2015cited by this paper
• Cardiotoxicity during invasive pneumococcal disease.

  2015cited by this paper
• Professions and Working Conditions Associated With Community-Acquired Pneumonia.

  2015cited by this paper
• Antibiotic treatment strategies for community-acquired pneumonia in adults.

  2015cited by this paper
• Nasal colonization and lower respiratory tract infections with methicillin-resistant Staphylococcus aureus.

  2015cited by this paper
• The impact of multimorbidity on short-term events in patients with community-acquired pneumonia: prospective cohort study.

  2015cited by this paper
• Clinical Factors Associated with Negative Urinary Antigen Tests Implemented for the Diagnosis of Community-Acquired Pneumococcal Pneumonia in Adult Patients

  2015cited by this paper
• The effect of simvastatin on inflammatory cytokines in community-acquired pneumonia: a randomised, double-blind, placebo-controlled trial

  2015cited by this paper
• Polysaccharide conjugate vaccine against pneumococcal pneumonia in adults.

  2015cited by this paper
• Ceftaroline: clinical and microbiology experience with focus on methicillin-resistant Staphylococcus aureus after regulatory approval in the USA.

  2015cited by this paper
• Professions and Working Conditions Associated With Community-Acquired Pneumonia.

  2015cited by this paper
• Assessment of oxygenation and comorbidities improves outcome prediction in patients with community‐acquired pneumonia with a low CRB‐65 score

  2015cited by this paper
• Detection and serotyping of pneumococci in community acquired pneumonia patients without culture using blood and urine samples

  2015cited by this paper
• Macrolides and Mortality in Critically Ill Patients With Community-Acquired Pneumonia: A Systematic Review and Meta-Analysis*

  2014cited by this paper
• Tobacco smoking increases the risk for death from pneumococcal pneumonia.

  2014cited by this paper
• Validation of sputum Gram stain for treatment of community-acquired pneumonia and healthcare-associated pneumonia: a prospective observational study

  2014cited by this paper
• Rapid detection of Mycoplasma pneumoniae and its macrolide-resistance mutation by Cycleave PCR.

  2014cited by this paper
• The value of signs and symptoms in differentiating between bacterial, viral and mixed aetiology in patients with community-acquired pneumonia.

  2014cited by this paper
• Risk stratification for cardiac complications in patients hospitalized for community-acquired pneumonia.

  2014cited by this paper
• Ruling out Legionella in community-acquired pneumonia.

  2014cited by this paper
• Effectiveness of the 23-valent pneumococcal polysaccharide vaccine against community-acquired pneumonia in the general population aged ≥ 60 years: 3 years of follow-up in the CAPAMIS study.

  2014cited by this paper
• Serum C-Reactive Protein as an Adjunct for Identifying Complicated Parapneumonic Effusions

  2014cited by this paper
• Rates and risk factors for recurrent pneumonia in patients hospitalized with community-acquired pneumonia: population-based prospective cohort study with 5 years of follow-up.

  2014cited by this paper
• Community-acquired lung respiratory infections in HIV-infected patients: microbial aetiology and outcome

  2014cited by this paper
• Prehospital use of inhaled corticosteroids and point prevalence of pneumonia at the time of hospital admission: secondary analysis of a multicenter cohort study.

  2014cited by this paper
• Serial quantification of procalcitonin (PCT) predicts clinical outcome and prognosis in patients with community-acquired pneumonia (CAP).

  2014cited by this paper
• Predictors of Viral Pneumonia in Patients with Community-Acquired Pneumonia

  2014cited by this paper
• Corticosteroids as adjunctive treatment in community-acquired pneumonia.

  2014cited by this paper
• Clinical features, risk factors and treatment of fulminant Mycoplasma pneumoniae pneumonia: a review of the Japanese literature.

  2014cited by this paper
• Patients with community acquired pneumonia admitted to European intensive care units: an epidemiological survey of the GenOSept cohort

  2014cited by this paper
• A 16-year prospective study of community-onset bacteremic Acinetobacter pneumonia: low mortality with appropriate initial empirical antibiotic protocols.

  2014cited by this paper
• Proton pump inhibitors and the risk of hospitalisation for community-acquired pneumonia: replicated cohort studies with meta-analysis

  2013cited by this paper
• A new strategy for healthcare-associated pneumonia: a 2-year prospective multicenter cohort study using risk factors for multidrug-resistant pathogens to select initial empiric therapy.

  2013cited by this paper
• Community-acquired pneumonia during the first post-pandemic influenza season: A prospective, multicentre cohort study

  2013cited by this paper
• Significance of Anaerobes and Oral Bacteria in Community-Acquired Pneumonia

  2013cited by this paper
• Rainfall Is a Risk Factor for Sporadic Cases of Legionella pneumophila Pneumonia

  2013cited by this paper
• How important is methicillin-resistant Staphylococcus aureus as a cause of community-acquired pneumonia and what is best antimicrobial therapy?

  2013cited by this paper
• An evaluation of clinical stability criteria to predict hospital course in community-acquired pneumonia.

  2013cited by this paper
• Role of the Neutrophil-Lymphocyte Count Ratio in the Differential Diagnosis between Pulmonary Tuberculosis and Bacterial Community-Acquired Pneumonia

  2013cited by this paper
• An initiative offering free pneumococcal vaccination to victims of the Great East Japan earthquake

  2013cited by this paper
• Relationship between the Use of Inhaled Steroids for Chronic Respiratory Diseases and Early Outcomes in Community-Acquired Pneumonia

  2013cited by this paper
• Severe community‐acquired pneumonia treated with β‐lactam–respiratory quinolone vs. β‐lactam–macrolide combination

  2013cited by this paper
• Chest ultrasonography as a replacement for chest radiography for community-acquired pneumonia.

  2013cited by this paper
• Positive urinary antigen tests for Streptococcus pneumoniae in community-acquired pneumonia: a 7-year retrospective evaluation of health care cost and treatment consequences

  2013cited by this paper
• Estimating the Burden of Pneumococcal Pneumonia among Adults: A Systematic Review and Meta-Analysis of Diagnostic Techniques

  2013cited by this paper
• Community-Acquired Legionella pneumophila Pneumonia

  2013cited by this paper
• Microbiology and prognostic factors of hospital- and community-acquired aspiration pneumonia in respiratory intensive care unit.

  2013cited by this paper
• Coxiella burnetii (Q fever) as a cause of community-acquired pneumonia during the warm season in Germany

  2013cited by this paper
• Impact of serum C-reactive protein measurements in the first 2 days on the 30-day mortality in hospitalized patients with severe community-acquired pneumonia: a cohort study.

  2013cited by this paper
• The diagnostic value of serum procalcitonin, IL-10 and C-reactive protein in community acquired pneumonia and tuberculosis.

  2013cited by this paper
• Pneumonic and nonpneumonic exacerbations of COPD: inflammatory response and clinical characteristics.

  2013cited by this paper
• Risk stratification and prognosis of acute cardiac events in hospitalized adults with community-acquired pneumonia.

  2013cited by this paper
• Comorbid pulmonary disease and risk of community-acquired pneumonia in COPD patients.

  2013cited by this paper
• Comparison of clinical features and outcomes of hospitalized adult patients with novel influenza A (H1N1) pneumonia and other pneumonia.

  2013cited by this paper
• IDSA/ATS minor criteria aid pre-intensive care unit resuscitation in severe community-acquired pneumonia

  2013cited by this paper
• Diagnostic, therapeutic and economic consequences of a positive urinary antigen test for Legionella spp. in patients admitted with community-acquired pneumonia: a 7-year retrospective evaluation

  2013cited by this paper
• Inactivated Influenza Vaccines for Prevention of Community-Acquired Pneumonia: The Limits of Using Nonspecific Outcomes in Vaccine Effectiveness Studies

  2013cited by this paper
• Should azithromycin no longer be considered a drug of choice for community-acquired pneumonia because of its potential to cause cardiovascular death?

  2013cited by this paper
• Body mass index and risk of pneumonia: a systematic review and meta‐analysis

  2013cited by this paper
• Inhaled corticosteroids and risk of recurrent pneumonia: a population-based, nested case-control study.

  2013cited by this paper
• What is the best antimicrobial treatment for severe community-acquired pneumonia (including the role of steroids and statins and other immunomodulatory agents).

  2013cited by this paper
• [Multidisciplinary guidelines for the management of community-acquired pneumonia].

  2013cited by this paper
• Epidemiología de la neumonía adquirida en la comunidad

  2013cited by this paper
• Transmission of macrolide-resistant Mycoplasma pneumoniae within a family

  2013cited by this paper
• Utility of two biomarkers for directing care among patients with non-severe community-acquired pneumonia

  2012cited by this paper
• Rapid effectiveness of minocycline or doxycycline against macrolide-resistant Mycoplasma pneumoniae infection in a 2011 outbreak among Japanese children.

  2012cited by this paper
• Are proton pump inhibitors associated with the development of community-acquired pneumonia? A meta-analysis

  2012cited by this paper
• Corticosteroids in the Treatment of Community-Acquired Pneumonia in Adults: A Meta-Analysis

  2012cited by this paper
• Angiotensin‐converting enzyme inhibitor use and pneumonia risk in community‐dwelling older adults: results from a population‐based case–control study

  2012cited by this paper
• Prediction of severe community-acquired pneumonia: a systematic review and meta-analysis

  2012cited by this paper
• Single versus combination antibiotic therapy in adults hospitalised with community acquired pneumonia

  2012cited by this paper
• Epidemiology of community acquired pneumonia.

  2012cited by this paper
• The impact of benzodiazepines on occurrence of pneumonia and mortality from pneumonia: a nested case-control and survival analysis in a population-based cohort

  2012cited by this paper
• Predictive factors, microbiology and outcome of patients with parapneumonic effusion

  2011cited by this paper
• Expanded clinical presentation of community-acquired methicillin-resistant Staphylococcus aureus pneumonia.

  2010cited by this paper
• C-reactive protein for discriminating treatment failure from slow responding pneumonia.

  2010cited by this paper
• A prediction rule for estimating the risk of bacteremia in patients with community-acquired pneumonia.

  2009cited by this paper
• Risk factors and outcome of community‐acquired pneumonia due to Gram‐negative bacilli

  2009cited by this paper
• Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults

  2007cited by this paper
• Assessment of mortality after long-term follow-up of patients with community-acquired pneumonia.

  2003cited by this paper
• A prediction rule to identify low-risk patients with community-acquired pneumonia.

  1997cited by this paper
• Community-acquired pneumonia.

  1995cited by this paper

• Clinical Characteristics and Microorganisms Isolated in Community-Acquired Pneumonia in the COVID-19 Period

  2024cites this paper
• NEUMONÍA ADQUIRIDA EN LA COMUNIDAD (NAC)

  2022cites this paper
• [Epidemiology and management of community acquired pneumonia: more than 10 years experience].

  2018cites this paper
• Key concepts in community-acquired pneumonia.

  2016cites this paper
• Mensajes claves en la neumonía adquirida en la comunidad

  2016cites this paper